Copyright
©The Author(s) 2020.
World J Gastroenterol. Jul 28, 2020; 26(28): 4140-4150
Published online Jul 28, 2020. doi: 10.3748/wjg.v26.i28.4140
Published online Jul 28, 2020. doi: 10.3748/wjg.v26.i28.4140
Groups of patients | Bax–Bcl-xL | |||
n | P value | r | ||
All | 115 | < 0.001 | 0.556a | |
Age(yr) | ≤ 60 | 39 | < 0.001 | 0.575a |
> 60 | 74 | < 0.001 | 0.530a | |
Sex | Male | 60 | < 0.001 | 0.453a |
Female | 54 | < 0.001 | 0.643a | |
Localization | Rectum | 48 | < 0.001 | 0.490a |
Colon | 66 | < 0.001 | 0.594a | |
HP–type | A | 93 | < 0.001 | 0.546a |
MA | 22 | 0.013 | 0.519a | |
G | G2 | 80 | < 0.001 | 0.523a |
G3 | 34 | < 0.001 | 0.543a | |
T | pT1 + pT2 | 10 | 0.537 | 0.222 |
pT3 + pT4 | 105 | < 0.001 | 0.577a | |
N | pN (-) | 55 | < 0.001 | 0.509a |
pN (+) | 60 | < 0.001 | 0.582a |
- Citation: Lomperta K, Jakubowska K, Grudzinska M, Kanczuga-Koda L, Wincewicz A, Surmacz E, Sulkowski S, Koda M. Insulin receptor substrate 1 may play divergent roles in human colorectal cancer development and progression. World J Gastroenterol 2020; 26(28): 4140-4150
- URL: https://www.wjgnet.com/1007-9327/full/v26/i28/4140.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i28.4140